PROVOST MIRIAM (VP of US Regulatory & FDA Rel.) received a stock award from TRANSMEDICS GROUP, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/22/2023ACC: 0000899243-23-005899
Officer· VP of US Regulatory & FDA Rel.
Since May 2019
+14.39K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
14.39K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.68K
Price / share
—
Trade value
—
% of position
37.5%
2/20/2023
15.15K→20.84K
Total
Net shares
+5.68K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2023 | A · Award | +5.68K | — | — | 37.5% | 15.15K | 20.84K |
| Total | +5.68K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
8.71K shares
Shares
+8.71K
Strike price
66.10
Held after
8.71K
Exercisable
—
2/20/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock8.71K shares | 2/20/2023 | A · Award | +8.71K | 66.10 | — | 8.71K |